Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF), a leading digital cannabis education and analytics company, is pleased to announce a definitive partnership with Seed Technology, a California, USA based interactive customer-focused cannabis education platform, granting Cannvas exclusive Canadian rights to distribute co-branded kiosks and related technology to medical clinics and dispensaries across Canada.

“Seed Technology has established itself as a premier purveyor of cannabis education to customers at dispensaries across the United States and we are excited to strategically partner with them and introduce an innovative co-branded concept to a Canadian market craving evidence-based information on cannabis and its potential health benefits,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Partnering with Seed allows us to offer a wider range of cannabis education products and services through our Cannvas Kiosk initiative to better serve our partners and deliver accessible and unbiased cannabis learning resources to as many Canadians as possible.”


Developed by Horizon Display – leading interactive experts providing and enhancing digital solutions for top brands such as Intel, Tesla, Nike, Disney and more for over 10 years – Seed was created to provide dispensaries with an advanced tool to improve customer experience, support staff and move product. Collaborating with a team of interactive education experts, scientists and cannabis industry specialists, Seed compiles accurate and timely information about cannabis and related products and transforms its research into one of the most advanced interactive education platforms in use at American dispensaries today.

The partnership allows for minimal capital requirements from Cannvas, as the Company gains access to Seed’s existing facilities and services, including its comprehensive in-house system for the manufacturing, distribution and content creation of its kiosks. Plans are in the works to integrate Cannvas – and now Seed – learning kiosks with select health clinics and platforms from coast to coast whereby users engaging with the kiosk have an opportunity to follow up with a licensed medical practitioner, should they so choose, and these clinics or platforms will be among their options. Cannvas and Seed will also collaborate on integrating Cannvas.Me technology and content into Seed kiosks to further improve accessibility to free, unbiased and physician-backed education about the potential health benefits of medical and adult-use cannabis.

“This is a wonderful opportunity for all Canadians curious about cannabis consumption but unsure where to turn for reliable, accurate and timely education on its potential health benefits,” said Daniel Davidzon, Director of Strategy and Education, Cannvas MedTech Inc. “Bringing the Seed kiosk brand to Canada increases our chances of reaching active and potential cannabis consumers where they shop, eat, work and live through on-site learning resources like the Cannvas.Me platform and equipping them with the information they need to make informed decisions on cannabis usage prior to speaking to their health care provider.”

About Seed
Seed is developed by Horizon Display—leading interactive experts who have been providing digital solutions for top brands and enhancing retail environments and experiences for over 10 years. Seed was developed to provide dispensaries with an advanced tool to enhance the buying experience for their customers, support their staff, and sell more product. To create Seed, its team of researchers logged thousands of hours across several states speaking to scientists and industry specialists to compile the most up-to-date information about cannabis and related products. Its engineers, interactive education experts and designers then took that content to create one of the most advanced interactive education platforms available in dispensaries today. For more information, please visit getseed.io.

About Cannvas MedTech Inc.
Cannvas MedTech is a leading digital cannabis education and business technology company within the health sciences space. We design and build patient-centric platforms that enable our partners to harness the power of data to truly understand their customers.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.  For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on www.sedar.com.

For further information: ir@cannvasmedtech.com or visit cannvasmedtech.com

Related Links

https://cannvasmedtech.com

Click here to connect with Cannvas MedTech (CSE:MTEC) (Frankfurt:3CM) (OTC:CANVF) for an Investor Presentation. 

Source: www.newswire.ca

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) is pleased to announce that it has issued a total of 7,400,000 options pursuant to its incentive stock option plan (“Plan”) to management, employees and consultants. Each option entitles the holder to subscribe for one common share of the Company for $0.265 for a period of 5 years, subject to the terms of the Plan

The Company has also agreed to engage Aktiencheck.de AG, for €50,000 for a European marketing and news dissemination program. The length of such program depends upon the Company’s future news flow.

Keep reading... Show less
  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “www.faire.com”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/80230_8c77c54544bf884c_001.jpg

Keep reading... Show less